Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
09:00am, Monday, 12'th Aug 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
German panel endorses GSK, Pfizer RSV vaccines for elderly
09:18am, Thursday, 08'th Aug 2024
Germany's influential vaccine advisory panel said on Thursday that everyone in the country who is 75-years old or more should receive one of two new vaccines against the common respiratory infection R
Dividend Income: Lanny's July 2024 Summary
08:35am, Tuesday, 06'th Aug 2024
In July, we (my wife and I) received a dividend income total of $2,836.82. 2023 was up 24%. 7 months down in 2024 and the S&P 500 is still up almost 13%, despite the recent sell-offs. We have a high l
GSK wins Illinois court battle
02:28am, Tuesday, 06'th Aug 2024
GSK PLC (LSE:GSK, NYSE:GSK) has successfully refuted claims that its discontinued heartburn drug Zantac caused cancer after an Illinois jury found that the product was not responsible for plaintiff Ca
GSK wins latest trial over Zantac cancer claims
05:52pm, Monday, 05'th Aug 2024
GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness, a company spoke
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
02:22pm, Friday, 02'nd Aug 2024
On Thursday, Moderna Inc MRNA lowered its 2024 sales guidance due to weaker demand for its COVID-19 vaccines.
India's GlaxoSmithKline Pharma posts higher Q1 adjusted profit on strong demand
06:35am, Friday, 02'nd Aug 2024
India's GlaxoSmithKline Pharmaceuticals reported a higher first-quarter adjusted profit on Friday, driven by strong demand for its generic drugs and vaccines.
GSK cancer drug receives expanded approval from the US regulator
03:41am, Friday, 02'nd Aug 2024
The US Food and Drug Administration (FDA) has expanded the approval of GSK PLC (LSE:GSK, NYSE:GSK)'s Jemperli (dostarlimab) in combination with chemotherapy for the treatment of adult patients with pr
Here's Why GSK (GSK) is a Strong Value Stock
10:42am, Thursday, 01'st Aug 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GSK Q2 Earnings Review: Vaccine Issues Aside, A Strong Quarter
03:38pm, Wednesday, 31'st Jul 2024
UK-based Pharma giant GSK plc reported its Q2 earnings earlier today. GSK plc exceeded Q2 2024 expectations with revenue up 13%, operating profit up 18%, and EPS up 17%. GSK upgraded full-year guidanc
GSK: Good Earnings Report, But Risks Ahead (Rating Downgrade)
01:29pm, Wednesday, 31'st Jul 2024
GSK's H1 2024 earnings report is strong, with healthy sales growth, solid core EPS increase, and upgraded outlook, resulting in attractive market multiples. However, the outlook still indicates that i
GSK plc (GSK) Q2 2024 Earnings Call Transcript
12:24pm, Wednesday, 31'st Jul 2024
GSK plc (NYSE:GSK ) Q2 2024 Earnings Conference Call July 31, 2024 7:00 AM ET Company Participants Nick Stone - Head, IR Emma Walmsley - CEO Tony Wood - Chief Scientific Officer Luke Miels - Chief Com
GSK sees £1.2bn wiped from its value as investors grumble about vaccine miss
11:07am, Wednesday, 31'st Jul 2024
Around £1.2 billion was wiped from the value of GSK PLC (LSE:GSK, NYSE:GSK) after the drug giant's Q2 vaccine sales failed to pass muster with the City. Specifically, analysts at Shore Capital said t
GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance
10:26am, Wednesday, 31'st Jul 2024
GSK's revenues benefit from strong growth across the Specialty Medicines and General Medicines segments. It raises guidance for earnings and sales for the full year.
GSK Becomes Latest Pharma Firm To Lift Outlook
09:16am, Wednesday, 31'st Jul 2024
GSK (GSK) lifted its sales and earnings projections for the year, after a strong performance by its HIV and cancer drugs drove second-quarter sales higher.
